Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

Advanced Biomed Inc. completes IPO of 1.64 million shares, raising $6.56 million for cancer diagnostic advancements. Advanced Biomed Inc., a biotechnology company specializing in cancer detection ...

Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis ...

Tainan, Taiwan, March 07, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the "Company") (NASDAQ: ADVB), a biotechnology company focused on early screening and detection, diagnosis and staging ...

With more than three weeks left in the first quarter, the value of med-tech IPOs for 2025 already exceeds the funds raised ...

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

The global meningitis treatment industry, valued at USD 150.9 million in 2023, is projected to grow at a CAGR of 4.1% from ...

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...